By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hydra Biosciences, Inc. 

790 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-5230 Fax: 617-494-5245




Company News
Hydra Biosciences, Inc. To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/2/2015 11:24:37 AM
Hydra Biosciences, Inc. To Present At The 7th Annual Biotech Showcase Conference In San Francisco On Jan. 13 1/6/2015 11:41:58 AM
Hydra Biosciences, Inc. And Boehringer Ingelheim Corporation Announce Worldwide Collaboration To Develop Small-Molecule Inhibitors For The Treatment Of Central Nervous System Diseases And Disorders 4/24/2014 9:54:14 AM
Cubist Pharmaceuticals, Inc. (CBST) and Hydra Biosciences, Inc. Announce Plans to Begin Phase 1 Clinical Trial for Novel TRPA1 Modulator to Treat Acute Pain 1/10/2012 6:26:37 AM
Hydra Biosciences, Inc. and Cubist Pharmaceuticals, Inc. (CBST) Form Collaboration to Develop Novel Ion Channel Drugs for Pain Management 10/19/2009 8:43:13 AM
Research published in PNAS by Hydra Biosciences, Inc. is First Demonstration in Mammals that TRP Ion Channel Drug Can Treat Allergy-Induced Asthma 5/19/2009 10:00:12 AM
Hydra Biosciences, Inc. Raises $22 Million in Series D Financing 1/16/2009 6:46:30 AM
Hydra Biosciences, Inc. Bolsters Discovery and IP Capabilities with Key Additions to Executive Management Team 10/24/2008 8:43:45 AM
Hydra Biosciences, Inc. Raises $34M in Venture Capital 3/14/2008 12:15:34 PM
Hydra Biosciences, Inc. Announces Data Revealing the Crucial Role Played by the TRPA1 Ion Channel in a Standard Model of Pain Receptor Activation 8/7/2007 1:27:20 PM